Research output per year
Research output per year
Personal profile
About
Dr. Samuel Neuhut joined the medical staff at HCA Florida Aventura Hospital after completing his adult psychiatry residency at Jackson Memorial Hospital/ University of Miami Miller School of Medicine and then completing his Child and Adolescent Psychiatry fellowship at Jackson Memorial Hospital in Miami, Florida where he was the Chief Fellow.
Dr. Neuhut is a member of the American Psychiatric Association and the American Academy of Child and Adolescent Psychiatry. He is board certified in Psychiatry by the American Board of Psychiatry and Neurology. Dr. Neuhut was recognized as a member of the "Guide to America's Top Psychiatrists."
Related documents
Education/Academic qualification
Fellowship, Child and Adolescent Psychiatry, Jackson Memorial Hospital - Jackson Health System
2013 → 2015
Residency, Psychiatry, Jackson Memorial Hospital - Jackson Health System
2010 → 2013
MD, Rosalind Franklin University of Medicine and Science
… → 2009
Research Interests
- Child & Adolescent Psychiatry
Disciplines
- Medicine and Health Sciences
- Psychiatry
Research output
- 7 Article
-
Impact of Stimulants to Reduce Readmission for Aggressive Behavior in Children with Attention Deficit Hyperactivity Disorder and Autism Spectrum Disorder
Vittori, A., Jo, Y., Alvarez, C. & Neuhut, S. A., Apr 1 2021, In: Psychiatry.Research output: Contribution to journal › Article › peer-review
-
A Case of Untreated Multiple Sclerosis Presenting as Psychosis
Pagan, I., Deligent, R. & Neuhut, S., Nov 6 2020, In: HCA-NSU MD Research Day.Research output: Contribution to journal › Article › peer-review
-
Gabapentin for Post-Hospitalization Alcohol Relapse Prevention; Should Gabapentin Be Considered for FDA Approval in the Treatment of Alcohol Use Disorder?: A Case Presentation and Literature Review
Rutkofsky, I. H., Fisher, K. A., Villalba, C. L. A. & Neuhut, S., Jun 30 2020, In: Cureus. 12, 6Research output: Contribution to journal › Article › peer-review
-
Gabapentin for Post-Hospitalization Alcohol Relapse Prevention; Should Gabapentin Be Considered for FDA Approval in the Treatment of Alcohol Use Disorder?: A Case Presentation and Literature Review
Rutkofsky, I., Fisher, K. A., Alvarez, C. & Neuhut, S. A., Jun 30 2020, In: Neurology.Research output: Contribution to journal › Article › peer-review
-
Gabapentin for Post-Hospitalization Alcohol Relapse Prevention; Should Gabapentin Be Considered for FDA Approval in the Treatment of Alcohol Use Disorder?: A Case Presentation and Literature Review
Rutkofsky, I., Fisher, K. A., Alvarez, C., Neuhut, S. A. & Alvarez Villalba, C. L., Jun 30 2020, In: Neurology.Research output: Contribution to journal › Article › peer-review